Regenera Activa AMT to Treat Androgenetic Alopecia

A study conducted in Basrah, Iraq, involving 23 patients (7 males and 16 females) aged 20-65, evaluated the effectiveness of Regenera Activa AMT for treating Androgenetic Alopecia. The results showed that 60.9% of patients were satisfied with the treatment. Significant improvements were observed in hair classification scores, trichoscopy scores, hair fall, and hair length, with normal hair classification scores increasing from 4.3% to 35% and normal hair fall from 8.7% to 80%. The procedure is described as effective, simple, painless, and quick, suggesting it could potentially replace hair transplants in the future.